Sfmg, LLC Bristol Myers Squibb CO Transaction History

Sfmg, LLC

$1.21 Billion
Q3 2024

A detailed history of Sfmg, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sfmg, LLC holds 27,555 shares of BMY stock, worth $1.59 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

27,555

Previous 28,853 4.5%

Holding current value

$1.59 Million

Previous $1.2 Million 18.95%

% of portfolio

0.12%

Previous 0.11%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 25, 2024	SELL	$39.66 - $51.75 $51,478 - $67,171	-1,298 Reduced 4.5%	27,555 $1.43 Million
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $24,713 - $32,535	-614 Reduced 2.08%	28,853 $1.2 Million
Q1 2024 May 07, 2024	SELL	$47.98 - $54.4 $82,765 - $93,840	-1,725 Reduced 5.53%	29,467 $1.6 Million
Q4 2023 Jan 30, 2024	SELL	$48.48 - $57.85 $72,138 - $86,080	-1,488 Reduced 4.55%	31,192 $1.6 Million
Q3 2023 Nov 06, 2023	SELL	$57.89 - $64.73 $8,162 - $9,126	-141 Reduced 0.43%	32,680 $1.9 Million
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $16,054 - $17,826	-252 Reduced 0.76%	32,821 $2.1 Million
Q1 2023 May 01, 2023	SELL	$65.71 - $74.53 $175,051 - $198,547	-2,664 Reduced 7.45%	33,073 $2.29 Million
Q4 2022 Jan 25, 2023	SELL	$68.48 - $81.09 $17,325 - $20,515	-253 Reduced 0.7%	35,737 $0
Q3 2022 Oct 20, 2022	BUY	$0.13 - $76.84 $16 - $9,912	129 Added 0.36%	35,990 $2.49 Million
Q2 2022 Aug 08, 2022	SELL	$72.62 - $79.98 $302,898 - $333,596	-4,171 Reduced 10.42%	35,861 $2.76 Million
Q1 2022 Apr 21, 2022	SELL	$61.48 - $73.72 $605,147 - $725,625	-9,843 Reduced 19.74%	40,032 $2.92 Million
Q4 2021 Jan 31, 2022	BUY	$53.63 - $62.52 $101,092 - $117,850	1,885 Added 3.93%	49,875 $3.11 Million
Q3 2021 Nov 01, 2021	SELL	$59.17 - $69.31 $21,123 - $24,743	-357 Reduced 0.74%	47,990 $2.84 Million
Q2 2021 Aug 06, 2021	BUY	$61.91 - $67.42 $329,856 - $359,213	5,328 Added 12.39%	48,347 $3.23 Million
Q1 2021 May 03, 2021	SELL	$59.34 - $66.74 $112,746 - $126,805	-1,900 Reduced 4.23%	43,019 $2.72 Million
Q4 2020 Feb 02, 2021	SELL	$57.74 - $65.43 $12,876 - $14,590	-223 Reduced 0.49%	44,919 $2.79 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $222,426 - $246,477	3,873 Added 9.38%	45,142 $2.72 Million
Q2 2020 Aug 03, 2020	BUY	$54.82 - $64.09 $1.72 Million - $2.01 Million	31,416 Added 318.85%	41,269 $2.43 Million
Q1 2020 May 08, 2020	BUY	$46.4 - $67.43 $31,644 - $45,987	682 Added 7.44%	9,853 $549,000
Q4 2019 Feb 05, 2020	BUY	$49.21 - $64.19 $98 - $128	2 Added 0.02%	9,171 $589,000
Q3 2019 Oct 29, 2019	BUY	$42.77 - $50.71 $85 - $101	2 Added 0.02%	9,169 $465,000
Q2 2019 Aug 05, 2019	BUY	$44.62 - $49.34 $61,709 - $68,237	1,383 Added 17.77%	9,167 $416,000
Q3 2018 Nov 15, 2018	SELL	$55.19 - $62.25 $6,070 - $6,847	-110 Reduced 1.39%	7,784 $395,000
Q2 2018 Aug 08, 2018	BUY	$50.53 - $62.98 $85,648 - $106,751	1,695 Added 27.34%	7,894 $437,000
Q1 2018 May 10, 2018	SELL	$59.92 - $68.98 $11,984 - $13,796	-200 Reduced 3.13%	6,199 $392,000
Q4 2017 Feb 09, 2018	BUY	$59.94 - $65.35 $11,988 - $13,069	200 Added 3.23%	6,399 $392,000
Q3 2017 Nov 07, 2017	BUY	$55.23 - $63.74 $342,370 - $395,124	6,199	6,199 $395,000

Others Institutions Holding BMY

# of Institutions

2,537

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sfmg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sfmg, LLC with notifications on news.

Account